On the nature of hypertrophic scars and keloids: a review.
暂无分享,去创建一个
M Kon | M. Kon | J. Schalkwijk | F B Niessen | P H Spauwen | J Schalkwijk | F. Niessen | P. Spauwen | Joost Schalkwijk
[1] S. Pollack,et al. The surgical treatment of keloids. , 1982, The Journal of dermatologic surgery and oncology.
[2] C. Zouboulis,et al. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. , 1993, Archives of dermatology.
[3] T. Tuan,et al. The molecular basis of keloid and hypertrophic scar formation. , 1998, Molecular medicine today.
[4] C. Kischer,et al. The histiotypic organization of the hypertrophic scar in humans. , 1972, The Journal of investigative dermatology.
[5] Laser Treatment of Scars , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[6] A. Ghahary,et al. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. , 1995, The Journal of surgical research.
[7] T. Wong,et al. Intralesional interferon α‐2b has no effect in the treatment of keloids , 1994 .
[8] J. Fox,et al. Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. , 1993, The American journal of pathology.
[9] J. Murray,et al. Keloids and Hypertrophic Scars , 2015 .
[10] H Kresse,et al. Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.
[11] T. Tuan,et al. Modulation of Collagen Synthesis by Transforming Growth Factor‐β in Keloid and Hypertrophic Scar Fibroblasts , 1994, Annals of plastic surgery.
[12] N. Swanson,et al. Basic mechanisms in the healing cutaneous wound. , 1986, The Journal of dermatologic surgery and oncology.
[13] A. P. Kelly,et al. Laser treatment of keloids: A clinical trial and an in vitro study with Nd:YAG laser , 1984, Lasers in surgery and medicine.
[14] B. Berman,et al. Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. , 1995, The Journal of investigative dermatology.
[15] I. Leigh,et al. Activated keratinocytes in the epidermis of hypertrophic scars. , 1998, The American journal of pathology.
[16] H. Dustan. Growth factors and racial differences in severity of hypertension and renal diseases , 1992, The Lancet.
[17] I. Ono,et al. Effects of prostaglandin E1 on cultured dermal fibroblasts from normal and hypertrophic scarred skin. , 1997, Journal of dermatological science.
[18] B. Berman,et al. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin , 1990, The British journal of dermatology.
[19] G. Gabbiani,et al. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[20] J. Risteli,et al. Synthesis of type I collagen in healing wounds in humans. , 1991, Annals of surgery.
[21] J. Uitto,et al. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. , 1985, Archives of dermatology.
[22] C. H. Wells,et al. TISSUE GASES IN HUMAN HYPERTROPHIC BURN SCARS , 1978, Plastic and Reconstructive Surgery.
[23] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[24] Dockery Gl,et al. Treatment of hypertrophic and keloid scars with SILASTIC Gel Sheeting. , 1994 .
[25] R. C. Lee,et al. The problem scar. , 1998, Clinics in plastic surgery.
[26] D. Messadi,et al. Binding and internalization of hyaluronate by human cutaneous fibroblasts. , 1992, Matrix.
[27] R. Davey,et al. Current materials and techniques used in a burn scar management programme. , 1987, Burns, including thermal injury.
[28] R. Ward,et al. Pressure therapy for the control of hypertrophic scar formation after burn injury. A history and review. , 1991, The Journal of burn care & rehabilitation.
[29] W. Laug,et al. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. , 1996, The Journal of investigative dermatology.
[30] M. Shetlar,et al. The Hypertrophic Scar. Glycoprotein and Collagen Components of Burn Scars , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[31] D. Heimbach,et al. A Comparison of Intramarginal and Extramarginal Excision of Hypertrophic Burn Scars , 1988, Plastic and reconstructive surgery.
[32] J. Davidson,et al. Glucocorticoid regulation of elastin synthesis in human fibroblasts: down-regulation in fibroblasts from normal dermis but not from keloids. , 1995, The Journal of investigative dermatology.
[33] R. Clark. Basics of cutaneous wound repair. , 1993, The Journal of dermatologic surgery and oncology.
[34] P. Mullaney,et al. Corneal keloid from unusual penetrating trauma. , 1995, Journal of pediatric ophthalmology and strabismus.
[35] A. Garg,et al. Inseparable iduronic acid-containing proteoglycan PG(IdoA) preparations of human skin and post-burn scar tissues: evidence for elevated levels of PG(IdoA)-I in hypertrophic scar by N-terminal sequencing. , 1996, Carbohydrate research.
[36] G Bottiroli,et al. Primary fluorescence of rat muscle after CO2 laser thermal injury , 1984, Lasers in surgery and medicine.
[37] C. Boyadjiev,et al. Histomorphologic changes in keloids treated with Kenacort. , 1995, The Journal of trauma.
[38] S. Jee,et al. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. , 1995, The Journal of surgical research.
[39] J. Russell,et al. CELL SIZE AND GROWTH CHARACTERISTICS OF CULTURED FIBROBLASTS ISOLATED FROM NORMAL AND KELOID TISSUE , 1976, Plastic and reconstructive surgery.
[40] I. Maruyama,et al. Marked increase in plasma interleukin-6 in burn patients. , 1992, The Journal of laboratory and clinical medicine.
[41] Winson W. Tang,et al. Myofibroblast and α1(III) collagen expression in experimental tubulointerstitial nephritis , 1997 .
[42] J. Seyer,et al. Modulation of fibroblast functions by interleukin 1: increased steady- state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta , 1988, The Journal of cell biology.
[43] R. Davey,et al. Silicone gel: a new treatment for burn scars and contractures. , 1983, Burns, including thermal injury.
[44] J. Uitto,et al. Ultrastructural Characteristics of Keloid Fibroblasts , 1988, The American Journal of dermatopathology.
[45] I. K. Cohen,et al. Hyaluronic acid metabolism in keloid fibroblasts. , 1995, Journal of pediatric surgery.
[46] A. Bailey,et al. Collagen polymorphism in experimental granulation tissue. , 1975, Biochemical and Biophysical Research Communications - BBRC.
[47] I. K. Cohen,et al. Immunoglobulin, Complement, and Histocompatibility Antigen Studies in Keloid Patients , 1979, Plastic and reconstructive surgery.
[48] E. Peacock. Pharmacologic Control of Surface Scarring in Human Beings , 1981, Annals of surgery.
[49] J. Russell,et al. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Galli,et al. Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: Role for mast cell tumor necrosis factor-α and transforming growth factor-β1 , 1997 .
[51] T. Tuan,et al. Role of Growth Factors in Scar Contraction: An In Vitro Analysis , 1996, Annals of plastic surgery.
[52] Raphael C Lee,et al. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. , 1990, The Journal of surgical research.
[53] P. Hebda,et al. Mast cell and myofibroblast in wound healing. , 1993, Dermatologic clinics.
[54] Ramakrishnan Km,et al. Study of 1,000 patients with keloids in South India. , 1974, Plastic and reconstructive surgery.
[55] N. Perelman,et al. Alteration of collagen composition and cross-linking in keloid tissues. , 1990, Matrix.
[56] B. Berman,et al. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. , 1989, Journal of the American Academy of Dermatology.
[57] A. J. Nemeth. Keloids and hypertrophic scars. , 1993, The Journal of dermatologic surgery and oncology.
[58] W. Larrabee,et al. Myofibroblasts in head and neck surgery. An experimental and clinical study. , 1988, Archives of otolaryngology--head & neck surgery.
[59] P. Weiss,et al. Sternal Keloids: Successful Treatment Employing Surgery and Adjunctive Radiation , 1993, Annals of plastic surgery.
[60] E. Kaplan,et al. Pathologic scar formation. Morphologic and biochemical correlates. , 1977, The American journal of pathology.
[61] G. Gabbiani,et al. The cellular derivation and the life span of the myofibroblast. , 1996, Pathology, research and practice.
[62] A. Gown,et al. The fibroblast-like nature of myofibroblast , 1988 .
[63] W. Lewis,et al. Hypertrophic scar: a genetic hypothesis. , 1990, Burns : journal of the International Society for Burn Injuries.
[64] W. Jung,et al. Studies on human scar tissue proteoglycans. , 1985, The Journal of investigative dermatology.
[65] Z. Werb,et al. Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[66] D. Jackson,et al. Collagen biosynthesis in normal and hypertrophic scars and keloid as a function of the duration of the scar , 1975, The British journal of surgery.
[67] K. Katagiri,et al. The Proteoglycans in Hypertrophic Scar , 1986, The Journal of dermatology.
[68] H. Linares,et al. Early differential diagnosis between hypertrophic and nonhypertrophic healing. , 1974, The Journal of investigative dermatology.
[69] G. Weissmann,et al. Cartilage proteoglycans inhibit fibronectin-mediated adhesion , 1981, Nature.
[70] A. Limpens. The local treatment of hypertrophic scars and keloids with topical retinoic acid , 1980 .
[71] R. Landel,et al. The etiology of hypertrophic scar contracture: another view. , 1981, Plastic and reconstructive surgery.
[72] H. Linares. Proteoglycan-lymphocyte association in the development of hypertrophic scars. , 1990, Burns : journal of the International Society for Burn Injuries.
[73] R. Diegelmann,et al. Fibronectin gene transcription is enhanced in abnormal wound healing. , 1992, The Journal of investigative dermatology.
[74] A. Banes,et al. Increased proliferation in keloid fibroblasts wounded in vitro. , 1996, The Journal of surgical research.
[75] C. Heldin,et al. Effects of homodimeric isoforms of platelet-derived growth factor (PDGF-AA and PDGF-BB) on wound healing in rat. , 1992, The Journal of surgical research.
[76] M. Takigawa,et al. Cell proliferation kinetics of cultured human keratinocytes and fibroblasts measured using a monoclonal antibody , 1987, The British journal of dermatology.
[77] M. Heckmann,et al. Biphasic effects of interleukin-1 alpha on dermal fibroblasts: enhancement of chemotactic responsiveness at low concentrations and of mRNA expression for collagenase at high concentrations. , 1993, The Journal of investigative dermatology.
[78] R. Sherman,et al. Experience with the Nd:YAG Laser in the Treatment of Keloid Scars , 1988, Annals of plastic surgery.
[79] G. Gabbiani,et al. The biology of the myofibroblast. , 1992, Kidney international.
[80] M. Bray,et al. Role of ionizing irradiation for 393 keloids. , 1987, International journal of radiation oncology, biology, physics.
[81] L. Rosenberg,et al. Regulation of cell substrate adhesion: effects of small galactosaminoglycan-containing proteoglycans , 1992, The Journal of cell biology.
[82] N. I. Cruz,et al. Inhibition of Human Keloid Fibroblast Growth by Isotretinoin and Triamcinolone Acetonide In Vitro , 1994, Annals of plastic surgery.
[83] David J. Smith,et al. Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. , 1993, The Journal of investigative dermatology.
[84] C. Dinarello. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases , 1992, Current Biology.
[85] L. Schwartz,et al. Mast cells in human keloid, small intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase. , 1986, The American journal of pathology.
[86] A. Ghahary,et al. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. , 1996, The Journal of investigative dermatology.
[87] I. K. Cohen,et al. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro , 1979, Journal of cellular physiology.
[88] D. Foreman,et al. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. , 1995, Journal of cell science.
[89] A. Sclafani,et al. Prevention of Earlobe Keloid Recurrence with Postoperative Corticosteroid Injections Versus Radiation Therapy A Randomized, Prospective Study and Review of the Literature , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[90] S. Salasche,et al. Keloids of the earlobes: a surgical technique. , 1983, The Journal of dermatologic surgery and oncology.
[91] L. Matrisian,et al. Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. , 1988, The Journal of biological chemistry.
[92] H. Steenfos,et al. Growth factors and wound healing. , 1994, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[93] J. Uitto,et al. Elastic fibers in human skin: quantitation of elastic fibers by computerized digital image analyses and determination of elastin by radioimmunoassay of desmosine. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[94] C. Castagnoli,et al. Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury , 1990, Clinical and experimental immunology.
[95] J. Fulton. Silicone Gel Sheeting for the Prevention and Management of Evolving Hypertrophic and Keloid Scars , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[96] D. Larson. PROTEOGLYCANS AND COLLAGENASE IN HYPERTROPHIC SCAR FORMATION , 1978, Plastic and reconstructive surgery.
[97] I. K. Cohen,et al. Measurement of collagen biosynthesis during wound healing. , 1975, The Journal of surgical research.
[98] J A Carr-Collins,et al. Pressure techniques for the prevention of hypertrophic scar. , 1992, Clinics in plastic surgery.
[99] van den Helder Cj,et al. Sense and nonsense of scar creams and gels. , 1994 .
[100] H. E. Pierce. Postsurgical acrylic ear splints for keloids. , 1986, The Journal of Dermatologic Surgery and Oncology.
[101] T. Whipple,et al. Synovial Response to Laser Induced Carbon Ash Residue , 1984, Lasers in surgery and medicine.
[102] L. Ala‐Kokko,et al. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. , 1987, The Journal of investigative dermatology.
[103] K. Sone,et al. Hydration and occlusion treatment for hypertrophic scars and keloids. , 1992, British journal of plastic surgery.
[104] J. Uitto,et al. Combined use of in situ hybridization and unlabeled antibody peroxidase anti-peroxidase methods: simultaneous detection of type I procollagen mRNAs and factor VIII-related antigen epitopes in keloid tissue. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[105] R. Clark,et al. Mast cells and fibrosis. , 1987, Archives of dermatology.
[106] C. Dinarello. Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.
[107] D L Larson,et al. Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. , 1993, Burns : journal of the International Society for Burn Injuries.
[108] L. Rogers,et al. Intra-arterial hydrogen peroxide and tissue oxygenation , 1965 .
[109] K. S. Lee,et al. Collagen mRNA expression detected by in situ hybridization in keloid tissue. , 1991, Journal of dermatological science.
[110] R. Wb,et al. Keloids and hypertrophic scars: a comprehensive review. , 1989, Plastic and reconstructive surgery.
[111] I. Leigh,et al. Epidermal cytokines and their roles in cutaneous wound healing , 1991, The British journal of dermatology.
[112] T. K. Hunt,et al. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. , 1981, Surgery.
[113] K. Ichikawa,et al. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. , 1993, Japanese journal of pharmacology.
[114] E. Schönherr,et al. Co‐ordinate induction of collagen type I and biglycan expression in keloids , 1996, The British journal of dermatology.
[115] A. Ghahary,et al. Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars. , 1996, Clinical science.
[116] E. Ruoslahti,et al. Immunological evidence for two distinct chondroitin sulfate proteoglycan core proteins: differential expression in cartilage matrix deficient mice. , 1983, Developmental biology.
[117] Thomas A. Mustoe, MD, FACS,et al. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. , 1991, The Journal of clinical investigation.
[118] J. Elias,et al. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. , 1987, Journal of immunology.
[119] J. Evans,et al. Non-pressure treatment of hypertrophic scars. , 1985, Burns, including thermal injury.
[120] C. J. Smith,et al. The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. , 1987, The Journal of burn care & rehabilitation.
[121] W. Lawrence,et al. In search of the optimal treatment of keloids: report of a series and a review of the literature. , 1991, Annals of plastic surgery.
[122] L. Perry,et al. Evaluation of Silicone‐Gel Sheeting on Early Wound Healing of Linear Incisions , 1995, Annals of plastic surgery.
[123] M. Gold. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. A dermatologic experience. , 1993, The Journal of dermatologic surgery and oncology.
[124] F. Maquart,et al. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. , 1995, The Biochemical journal.
[125] Tredget Ee. The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics. , 1994 .
[126] R. W. Miller,et al. Keloids and neoplasms in the Rubinstein-Taybi syndrome. , 2006, Medical and pediatric oncology.
[127] C. Buchwald,et al. Keloids of the external ear. , 1992, ORL; journal for oto-rhino-laryngology and its related specialties.
[128] P. C. van de Kerkhof,et al. Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study , 1998, The Journal of pathology.
[129] B. Katz. Silicone gel sheeting in scar therapy. , 1995, Cutis.
[130] M. Yaron,et al. Synergistic, additive, and antagonistic effects of interleukin-1 beta, tumor necrosis factor alpha, and gamma-interferon on prostaglandin E, hyaluronic acid, and collagenase production by cultured synovial fibroblasts. , 1990, Arthritis and rheumatism.
[131] M. Rusnati,et al. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans , 1996, International journal of clinical & laboratory research.
[132] T. K. Hunt,et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. , 1983, Science.
[133] M. Pittelkow,et al. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature. , 1988, Journal of the American Academy of Dermatology.
[134] A. Kazeem,et al. The immunological aspects of keloid tumor formation , 1988, Journal of surgical oncology.
[135] R. Harper. Keloid fibroblasts in culture: abnormal growth behaviour and altered response to the epidermal growth factor. , 1989, Cell biology international reports.
[136] Frederick H. Silver,et al. Mechanical Analysis of Hypertrophic Scar Tissue: Structural Basis for Apparent Increased Rigidity , 1985 .
[137] T. Alster,et al. Laser treatment of hypertrophic scars, keloids, and striae. , 1997, Seminars in cutaneous medicine and surgery.
[138] D. Carney,et al. The Role of Thrombin and Thrombin Receptor Activating Peptide (TRAP-508) in Initiation of Tissue Repair , 1993, Thrombosis and Haemostasis.
[139] M. Longaker,et al. Hyaluronan and wound healing: a new perspective. , 1991, British journal of plastic surgery.
[140] B. Seckel,et al. Single-dose electron beam irradiation in treatment and prevention of keloids and hypertrophic scars. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[141] T. Hayakawa,et al. Changes in type of collagen during the development of human post-burn hypertrophic scars. , 1979, Clinica chimica acta; international journal of clinical chemistry.
[142] Y. Sawada. Alterations in Pressure under Elastic Bandages: Experimental and Clinical Evaluation , 1993, The Journal of dermatology.
[143] P. Omo-Dare. Genetic studies on keloid. , 1975, Journal of the National Medical Association.
[144] J. Russell,et al. Glucocorticoid receptors in human fibroblasts derived from normal dermis and keloid tissue. , 1984, The Journal of biological chemistry.
[145] T. Alster. Improvement of Erythematous and Hypertrophic Scars by the 585-nm Flashlamp-pumped Pulsed Dye Laser , 1994, Annals of plastic surgery.
[146] R. Diegelmann,et al. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing , 1989, Molecular and cellular biology.
[147] B. Berman,et al. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. , 1997, Journal of the American Academy of Dermatology.
[148] J. Seyer,et al. Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. , 1991, The Journal of clinical investigation.
[149] A. Ghahary,et al. Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor‐β in human post‐burn hypertrophic and mature scars , 1995, Histopathology.
[150] S. Hoffman. Radiotherapy for keloids. , 1982, Annals of plastic surgery.
[151] G. Schultz,et al. Growth factors and wound healing: biochemical properties of growth factors and their receptors. , 1993, American journal of surgery.
[152] W. Larrabee,et al. Management of scar contractures, hypertrophic scars, and keloids. , 1995, Otolaryngologic clinics of North America.
[153] J. Kiil. Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. , 1977, Scandinavian journal of plastic and reconstructive surgery.
[154] I. K. Cohen,et al. In Vitro Inhibition of Cell Growth, Collagen Synthesis, and Prolyl Hydroxylase Activity by Triamcinolone Acetonide 1 , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[155] B. Cosman,et al. CORRELATION OF KELOID RECURRENCE WITH COMPLETENESS OF LOCAL EXCISION: A Negative Report , 1972, Plastic and reconstructive surgery.
[156] J. Uitto,et al. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[157] T. Gowrishankar,et al. The 1996 Lindberg Award. Calcium antagonists alter cell shape and induce procollagenase synthesis in keloid and normal human dermal fibroblasts. , 1996, The Journal of burn care & rehabilitation.
[158] G F Pierce,et al. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. , 1992, The American journal of pathology.
[159] W. Larrabee,et al. Intralesional interferon gamma treatment for keloids and hypertrophic scars. , 1990, Archives of otolaryngology--head & neck surgery.
[160] J. Oluwasanmi. Keloids in the African. , 1974, Clinics in plastic surgery.
[161] R. Roberts,et al. Hypertrophic Sternal Scars: Silicone Gel Sheet versus Kenalog Injection Treatment , 1992, Plastic and reconstructive surgery.
[162] K. Bowering,et al. Adhesive contact media--an update on graft fixation and burn scar management. , 1991, Burns : journal of the International Society for Burn Injuries.
[163] S. M. Alhady. KELOIDS IN VARIOUS RACES A Review of 175 Cases , 1969, Plastic and reconstructive surgery.
[164] J. Forrester,et al. Glycosaminoglycans facilitate the movement of fibroblasts through three-dimensional collagen matrices. , 1989, Journal of cell science.
[165] J. Murray. Scars and keloids. , 1993, Dermatologic clinics.
[166] Thomas A. Mustoe, MD, FACS,et al. Topical silicone gel: a new treatment for hypertrophic scars. , 1989, Surgery.
[167] I. K. Cohen,et al. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. , 1993, Matrix.
[168] R. Timpl,et al. Binding of the proteoglycan decorin to collagen type VI. , 1992, The Journal of biological chemistry.
[169] A. Desmoulière,et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.
[170] R. Craig,et al. Collagen Biosynthesis in Normal Human Skin, Normal and Hypertrophic Scar and Keloid , 1975, European journal of clinical investigation.
[171] E. Bloch,et al. General Immune Reactivity in Keloid Patients , 1984, Plastic and reconstructive surgery.
[172] G. Schultz,et al. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. , 1993, American journal of surgery.
[173] Erkki Ruoslahti,et al. Proteoglycans as modulators of growth factor activities , 1991, Cell.
[174] M. H. Panabiere-Castaings,et al. Retinoic acid in the treatment of keloids. , 1988, The Journal of dermatologic surgery and oncology.
[175] J. Rosenbloom,et al. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. , 1984, The Journal of clinical investigation.
[176] P. Leung,et al. Mechanical characterisation of human postburn hypertrophic skin during pressure therapy. , 1987, Journal of biomechanics.
[177] W. Schürch,et al. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[178] C. Castagnoli,et al. TNF production and hypertrophic scarring. , 1993, Cellular immunology.
[179] M. Gibbons,et al. Experience with silastic gel sheeting in pediatric scarring. , 1994, The Journal of burn care & rehabilitation.
[180] N. Chowdri,et al. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. , 1992, British journal of plastic surgery.
[181] I. K. Cohen,et al. TISSUE ALPHA‐GLOBULINS IN KELOID FORMATION , 1977, Plastic and reconstructive surgery.
[182] J. Alexander,et al. Failure of topical steroids and vitamin E to reduce postoperative scar formation following reconstructive surgery. , 1986, The Journal of burn care & rehabilitation.
[183] G. Pierce. Macrophages: important physiologic and pathologic sources of polypeptide growth factors. , 1990, American journal of respiratory cell and molecular biology.
[184] D. Apfelberg,et al. Failure of carbon dioxide laser excision of keloids , 1990, Lasers in surgery and medicine.
[185] J. Uitto,et al. Interferon-gamma coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases (TIMP), expression in cultured keratinocytes. , 1995, The Journal of investigative dermatology.
[186] H. Wiggers,et al. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. , 1998, Journal of molecular and cellular cardiology.
[187] T. Nishikawa,et al. Tranilast inhibits collagen synthesis in normal, scleroderma and keloid fibroblasts at a late passage culture but not at an early passage culture. , 1995, Journal of dermatological science.
[188] I. K. Cohen,et al. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. , 1996, Plastic and reconstructive surgery.
[189] J. E. Norris. Hypertrophic scar and keloid. , 1991, Plastic and reconstructive surgery.
[190] M. Abdel-Fattah,et al. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Case report. , 1975, Plastic and reconstructive surgery.
[191] D. D. Datubo-Brown. Keloids: a review of the literature. , 1990, British journal of plastic surgery.
[192] B. Brent. The Role of Pressure Therapy in Management of Earlobe Keloids: Preliminary Report of a Controlled Study , 1978, Annals of plastic surgery.
[193] N. Pejnović,et al. Aberrant levels of cytokines within the healing wound after burn injury. , 1995, Archives of surgery.
[194] W. Weston,et al. Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivo. , 1986, Journal of the American Academy of Dermatology.
[195] J. E. Norris. The Effect of Carbon Dioxide Laser Surgery on the Recurrence of Keloids , 1991, Plastic and reconstructive surgery.
[196] J. Wrana,et al. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. , 1989, The Journal of biological chemistry.
[197] C. Kischer,et al. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. , 1982, Human pathology.
[198] S. Supe,et al. Treatment of keloids by 90Sr-90Y beta-rays. , 1991, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[199] Y. W. Tang,et al. Intra- and postoperative steroid injections for keloids and hypertrophic scars. , 1992, British journal of plastic surgery.
[200] D. Greenhalgh,et al. Expression of interleukin-1alpha, interleukin-6, and basic fibroblast growth factor by cultured skin substitutes before and after grafting to full-thickness wounds in athymic mice. , 1996, The Journal of trauma.
[201] K. Sone,et al. Treatment of scars and keloids with a cream containing silicone oil. , 1990, British journal of plastic surgery.
[202] E. Carter,et al. Proteoglycan synthesis in human skin and burn scar explant cultures. , 1991, Burns : journal of the International Society for Burn Injuries.
[203] N. Cruz-Korchin. Effectiveness of Silicone Sheets in the Prevention of Hypertrophic Breast Scars , 1996, Annals of plastic surgery.
[204] G. Hallmans,et al. Treatment of keloids and hypertrophic scars with adhesive zinc tape. , 1982, Scandinavian journal of plastic and reconstructive surgery.
[205] R. Bono,et al. Use of cryotherapy in the treatment of keloids. , 1993, The Journal of dermatologic surgery and oncology.
[206] S. Miyauchi,et al. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. , 1995, Acta dermato-venereologica.
[207] Y. Ryoo,et al. Effects of x-irradiation on survival and extracellular matrix gene expression of cultured keloid fibroblasts. , 1994, Journal of dermatological science.
[208] E. Deitch,et al. The clinical use of a tubular compression bandage, Tubigrip, for burn-scar therapy: a critical analysis. , 1985, Burns, including thermal injury.
[209] Darrell L. Henderson,et al. Argon and Carbon Dioxide Laser Treatment of Hypertrophic and Keloid Scars , 1984, Lasers in surgery and medicine.
[210] C. Perez,et al. Radiation therapy following keloidectomy: a 20-year experience. , 1989, International journal of radiation oncology, biology, physics.
[211] T. Alster,et al. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser , 1995, The Lancet.
[212] Gary R. Grotendorst,et al. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. , 1994, The Journal of investigative dermatology.
[213] D. Foreman,et al. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.
[214] D. Heinegård,et al. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.
[215] H. Dustan. Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? , 1995, Hypertension.
[216] A. Akanji,et al. CLINICAL, BIOCHEMICAL AND MORPHOLOGIC FEATURES OF ACNE KELOIDALIS IN A BLACK POPULATION , 1993, International journal of dermatology.
[217] M. Anscher,et al. Keloids treated with excision followed by radiation therapy. , 1994, Journal of the American Academy of Dermatology.
[218] A. Dhillon,et al. Hepatobiliary cystadenoma with mesenchymal stroma: expression of oestrogen receptors in formalin‐fixed tissue , 1995, Histopathology.
[219] F. Stucker,et al. An approach to management of keloids. , 1992, Archives of otolaryngology--head & neck surgery.
[220] S. Lowry. Cytokine mediators of immunity and inflammation. , 1993, Archives of Surgery.
[221] S. Phan,et al. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. , 1995, The Journal of investigative dermatology.
[222] K. Sone,et al. Release of Ofloxacin from silicone gel sheet. , 1993, British journal of plastic surgery.
[223] R. Page,et al. The role of inflammatory mediators in the pathogenesis of periodontal disease. , 1991, Journal of periodontal research.
[224] R. Diegelmann,et al. Growth factors in wound healing. , 1994, Clinics in dermatology.
[225] A. Bailey,et al. Characterization of the collagen of human hypertrophic and normal scars. , 1975, Biochimica et biophysica acta.
[226] R. Lavker,et al. Cutaneous mast cell depletion results from topical corticosteroid usage. , 1985, Journal of immunology.
[227] Y. Har-Shai,et al. Static-electric field induction by a silicone cushion for the treatment of hypertrophic and keloid scars. , 1998 .
[228] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[229] L. Fisher,et al. Decorin interacts with fibrillar collagen of embryonic and adult human skin. , 1991, Journal of structural biology.
[230] D. Studd,et al. "Oyster splints": a new compression device for the treatment of keloid scars of the ear. , 1983, British journal of plastic surgery.
[231] A. Vaheri,et al. Sequential appearance of fibronectin and collagen in experimental granulation tissue. , 1980, Laboratory investigation; a journal of technical methods and pathology.
[232] E. Deitch,et al. Hypertrophic burn scars: analysis of variables. , 1983, The Journal of trauma.
[233] U. Bertheim,et al. The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars. , 1994, British journal of plastic surgery.
[234] J. Milsom,et al. Collagen degradation in cultured keloid and hypertrophic scar tissue , 1973, The British journal of dermatology.
[235] Thomas A. Mustoe, MD, FACS,et al. Topical silicone gel for the prevention and treatment of hypertrophic scar. , 1991, Archives of surgery.
[236] I. Muir,et al. On the nature of keloid and hypertrophic scars. , 1990, British journal of plastic surgery.
[237] D. W. Friedman,et al. Regulation of collagen gene expression in keloids and hypertrophic scars. , 1993, The Journal of surgical research.
[238] A. Curtis,et al. The control of cell division by tension or diffusion , 1978, Nature.
[239] J. Davidson,et al. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. , 1991, The Journal of investigative dermatology.
[240] J. Peltonen,et al. Endothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts. , 1991, The Biochemical journal.
[241] R. Stern,et al. Age-dependent changes of hyaluronan in human skin. , 1994, The Journal of investigative dermatology.
[242] S. Suzuki,et al. Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDa protein. , 1990, The Journal of biological chemistry.
[243] A. Ghahary,et al. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. , 1997, The Surgical clinics of North America.
[244] A. Koda,et al. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. , 1993, Japanese journal of pharmacology.
[245] D Elliot,et al. The behaviour of presternal scars in a fair-skinned population. , 1985, Annals of the Royal College of Surgeons of England.
[246] C. Castagnoli,et al. Similar ectopic expression of ICAM-1 and HLA class II molecules in hypertrophic scars following thermal injury. , 1994, Burns : journal of the International Society for Burn Injuries.
[247] D. Apfelberg,et al. Preliminary report on use of the neodymium‐YAG laser in plastic surgery , 1987 .
[248] R. Diegelmann,et al. Keloid fibroblasts exhibit an altered response to TGF-beta. , 1992, The Journal of investigative dermatology.
[249] B. Berman,et al. Adjunct Therapies to Surgical Management of Keloids , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[250] R. Page,et al. Microcirculation in hypertrophic burn scars. , 1983, Burns, including thermal injury.
[251] J. E. Norris. Superficial X‐Ray Therapy in Keloid Management: A Retrospective Study of 24 Cases and Literature Review , 1995, Plastic and reconstructive surgery.
[252] G. Lemperle,et al. Elevated Levels of Testosterone Receptors in Keloid Tissue: An Experimental Investigation , 1997, Plastic and reconstructive surgery.
[253] C. Kischer,et al. Alteration of hypertrophic scars induced by mechanical pressure. , 1975, Archives of dermatology.
[254] W. Cunliffe,et al. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids , 1994, The British journal of dermatology.
[255] J. Lawrence. The aetiology of scars. , 1987, Burns, including thermal injury.
[256] A. Ghahary,et al. Fibroblasts from post-burn hypertrophic scar tissue synthesize less decorin than normal dermal fibroblasts. , 1998, Clinical science.
[257] G. Sonenshein,et al. NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts , 1992, The Journal of experimental medicine.
[258] L. D. Ketchum. Hypertrophic scars and keloids. , 1977, Clinics in plastic surgery.
[259] C. W. Martin,et al. The role of lymphocytes in wound healing. , 1990, British journal of plastic surgery.
[260] A. Reddi,et al. Persistence of Cartilage proteoglycan and link protein during matrix-induced endochondral bone development: an immunofluorescent study. , 1982, Developmental biology.
[261] K. Takehara,et al. Effects of various growth factors and histamine on cultured keloid fibroblasts. , 1995, Dermatology.
[262] T. Alster,et al. Treatment of Scars: A Review , 1997, Annals of plastic surgery.
[263] S. Wahl,et al. Lymphocyte-mediated activation of fibroblast proliferation and collagen production. , 1978, Journal of immunology.
[264] I. K. Cohen,et al. Collagenase in keloid biopsies and fibroblasts. , 1982, Connective tissue research.
[265] G. Gozzi,et al. VITAMIN E ADDED SILICONE GEL SHEETS FOR TREATMENT OF HYPERTROPHIC SCARS AND KELOIDS , 1995, International journal of dermatology.
[266] H. Moses,et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[267] T. Yotsuyanagi,et al. Treatment of dermal depth burn wounds with an antimicrobial agent-releasing silicone gel sheet. , 1990, Burns : journal of the International Society for Burn Injuries.
[268] G. Antoine,et al. Keloid formation on palmar surface of hand. , 1991, Journal of the National Medical Association.
[269] H. Dvorak,et al. Alterations in proteoglycan synthesis common to healing wounds and tumors. , 1991, The American journal of pathology.
[270] B. Berman,et al. Effects of a water-impermeable, non-silicone-based occlusive dressing on keloids. , 1996, Journal of the American Academy of Dermatology.
[271] J. V. Vande Berg,et al. Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. , 1991, The American journal of pathology.
[272] W. Nagler,et al. Compliance with pressure garment use in burn rehabilitation. , 1994, The Journal of burn care & rehabilitation.
[273] M P Goldman,et al. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. , 1995, Plastic and reconstructive surgery.
[274] H. Katai,et al. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.
[275] V. L. Lewis,et al. The Use of Antihistamine to Retard the Growth of Fibroblasts Derived from Human Skin, Scar, and Keloid , 1981, Plastic and reconstructive surgery.
[276] E. Peacock,et al. Biologic Basis for the Treatment of Keloids and Hypertrophic Scars , 1970, Southern medical journal.
[277] K. Sone,et al. A study of topical and systemic prostaglandin E1 and survival of experimental skin flaps. , 1993, British journal of plastic surgery.